Top news of the week: 22.12.2020.
Companies And Industries
The top 5 pharma M&A deals of 2020
2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout of Celegne and AbbVie’s acquisition of Allergan – accounted for almost 40% ...
Novartis buys neurology biotech Cadent for up to $770m
Novartis is to buy neuroscience drugs firm Cadent Therapeutics in a deal worth up to $770 million.
Four Potential Biotech Market Movers to Watch Going into 2021
As we eagerly look ahead to 2021, BioSpace spoke to four biotechs hoping to seize this opportunity in the first wave of COVID-19 vaccines and therapies – or make an impact in the second.
Here are the nominees for worst biopharma CEO of 2020
It's time for an annual tradition, but a year like no other requires a new way of drafting a list of worst biopharma CEOs.
Virtual Event: A look ahead at biotech in 2021
STAT’s biotech team takes the virtual stage to look back at how the biotech industry confronted the pandemic and forecast the year to come.
“This is the time for us to talk about the science”
COVID-19 vaccines are here—but how do we ensure people will get them when it’s their turn? BIO’s Dr. Michelle McMurry-Heath discussed this on CNN. Meanwhile, 2021 is shaping up to be a ...
Which Types of Continued Learning Can You List on a Resume?
While continued learning opportunities are easy to access and many are quite affordable, the real question is, can you list these courses on your resume? And if you do so, what will ...
Five Companies Earn Validation as FDA Recognizes New Breakthrough Therapies
Novartis' Iptacopan isn’t the only drug to receive Breakthrough Therapy designation this week. Several other experimental treatments were also awarded the designation.